|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,478.00 GBX | +1.58% |
|
+5.42% | -4.65% |
| 05-15 | Hikma Pharmaceuticals PLC Announces Change of Registered Office Address | CI |
| 05-09 | Hikma Pharmaceuticals Usa Inc. Announces Recall of Alendronate Sodium Oral Solution | CI |
| Capitalization | 4.27B 3.67B 3.36B 3.18B 5.87B 412B 5.97B 39.81B 15.57B 195B 16.02B 15.68B 678B | P/E ratio 2026 * |
10.3x | P/E ratio 2027 * | 9.33x |
|---|---|---|---|---|---|
| Enterprise value | 5.66B 4.87B 4.45B 4.21B 7.77B 546B 7.91B 52.75B 20.63B 258B 21.23B 20.77B 899B | EV / Sales 2026 * |
1.63x | EV / Sales 2027 * | 1.51x |
| Free-Float |
64.43% | Yield 2026 * |
4.31% | Yield 2027 * | 4.56% |
Last Transcript: Hikma Pharmaceuticals PLC
| 1 day | +1.58% | ||
| 1 week | +5.42% | ||
| Current month | +5.68% | ||
| 1 month | +7.18% | ||
| 3 months | -9.88% | ||
| 6 months | -6.28% | ||
| Current year | -4.65% |
| 1 week | 1,402 |  | 1,487 |
| 1 month | 1,311 | | 1,487 |
| Current year | 1,187 | | 1,691 |
| 1 year | 1,187 | | 2,164 |
| 3 years | 1,187 | | 2,360 |
| 5 years | 1,174.5 | | 2,703 |
| 10 years | 814.2 | | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 01/12/2025 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 26/02/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 26/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 14/10/2005 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 15/12/2025 |
Said Darwazah
CHM | Chairman | 69 | 15/05/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.91% | 0.16% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.58% | +5.42% | -28.53% | -19.06% | 4.19B | |
| -0.25% | +2.93% | +34.93% | +130.32% | 911B | |
| -0.30% | +2.26% | +50.38% | +44.31% | 554B | |
| -0.68% | +2.14% | +14.32% | +46.30% | 378B | |
| -0.42% | +2.05% | +26.19% | +13.82% | 333B | |
| +0.50% | +1.47% | +34.50% | +16.15% | 288B | |
| -0.42% | +2.28% | +29.48% | +30.97% | 287B | |
| -1.09% | +0.56% | +46.32% | -2.16% | 282B | |
| +0.31% | -2.73% | -34.26% | -49.84% | 198B | |
| +0.25% | -1.40% | +20.20% | +48.41% | 179B | |
| Average | +0.09% | +1.64% | +19.35% | +25.92% | 341.36B | |
| Weighted average by Cap. | -0.16% | +2.15% | +29.89% | +51.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.47B 2.98B 2.73B 2.58B 4.77B 335B 4.85B 32.33B 12.65B 158B 13.01B 12.73B 551B | 3.63B 3.13B 2.86B 2.7B 4.99B 351B 5.08B 33.88B 13.25B 166B 13.63B 13.34B 577B |
| Net income | 414M 356M 326M 309M 570M 40.03B 580M 3.86B 1.51B 18.89B 1.56B 1.52B 65.82B | 454M 390M 357M 338M 624M 43.82B 634M 4.23B 1.65B 20.68B 1.7B 1.67B 72.06B |
| Net Debt | 1.39B 1.19B 1.09B 1.03B 1.91B 134B 1.94B 12.94B 5.06B 63.23B 5.21B 5.09B 220B | 1.23B 1.06B 969M 917M 1.69B 119B 1.72B 11.48B 4.49B 56.14B 4.62B 4.52B 196B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/26 | 1,478.00 p | +1.58% | 1,022,877 |
| 19/05/26 | 1,455.00 p | +0.69% | 1,107,138 |
| 18/05/26 | 1,445.00 p | +0.35% | 422,356 |
| 15/05/26 | 1,440.00 p | +1.12% | 1,239,990 |
| 14/05/26 | 1,424.00 p | +0.14% | 557,310 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition